Resources / en Evaluation of rodent control to fight Lassa fever based on field data and mathematical modelling /resources/evaluation-rodent-control-fight-lassa-fever-based-field-data-and-mathematical-modelling The Natal multimammate mouse (Mastomys natalensis) is the reservoir host of Lassa virus, an arenavirus that causes Lassa haemorrhagic fever in humans in West Africa. Because no vaccine exists and therapeutic options are limited, preventing infection through rodent control and human behavioural measures is currently considered to be the only option. In order to assess the efficacy of rodent control, we performed a 4-year field experiment in rural Upper Guinea and developed a mathematical model to simulate different control strategies (annual density control, continuous density control, and rodent vaccination). For the field study, rodenticide baits were placed each year in three rural villages, while three other villages were used as controls. Rodents were trapped before and after every treatment and their antibody status and age were determined. Data from the field study were used to parameterize the mathematical model. In the field study, we found a significant negative effect of rodent control on seroprevalence, but this effect was small especially given the effort. Furthermore, the rodent populations recovered rapidly after rodenticide application, leading us to conclude that an annual control strategy is unlikely to significantly reduce Lassa virus spillover to humans. In agreement with this finding, the mathematical model suggests that the use of continuous control or rodent vaccination is the only strategy that could lead to Lassa virus elimination. These field and model results can serve as a guide for determining how long and frequent rodent control should be done in order to eliminate Lassa virus in rural villages. Thu, 06/20/2019 - 19:31 Dan /resources/evaluation-rodent-control-fight-lassa-fever-based-field-data-and-mathematical-modelling Ebola hemorrhagic fever outbreaks in Gabon 1994-1997 /resources/ebola-hemorrhagic-fever-outbreaks-gabon-1994-1997 Key findings From the end of 1994 to the beginning of 1995, 49 patients with hemorrhagic symptoms were hospitalized in the Makokou General Hospital in northeastern Gabon. Yellow fever (YF) virus was first diagnosed in serum by use of polymerase chain reaction followed by blotting, and a vaccination campaign was immediately instituted. The epidemic, known as the fall 1994 epidemic, ended 6 weeks later. However, some aspects of this epidemic were atypical of YF infection, so a retrospective check for other etiologic agents was undertaken. Ebola (EBO) virus was found to be present concomitantly with YF virus in the epidemic. Two other epidemics (spring and fall 1996) occurred in the same province. GP and L genes of EBO virus isolates from all three epidemics were partially sequenced, which showed a difference of ›0.1% in the base pairs. Sequencing also showed that all isolates were very similar to subtype Zaire EBO virus isolates from the Democratic Republic of the Congo. No serologic data were available from persons in Ogooue´-Ivindo Province before the first epidemic. This low percentage of seropositviity suggests that the circulation of EBO is a new phenomenon in the area, affecting mainly people living deep in the forest in temporary encampments. There are interesting demographic and ecologic differences between the sites of the first two epidemics. The disturbance of the forest integrity is one common feature between the two sites, but the one important difference is the permanence and the size of the population around Mayibout 2, which might permit the virus, once present in the area, to circulate within the human population. Both the reservoir and the vector for the EBO virus as still unknown. Recommendations  It is very clear that the use of simple barrier nursing methods in even the most basic of hospital settings is sufficient to limit the spread of this disease. Nosocomial spread of infection due to the lack of recognition of the disease and the dearth of training and material available to establish simple barrier nursing remains the root cause of most of the disease observed to date. From the public health point of view, this remains a basic goal for the prevention of EHF epidemics. Preventing primary infection certainly requires the identification of risk factors and the reservoir, something that continues to elude us. Fri, 03/29/2019 - 11:47 Dan /resources/ebola-hemorrhagic-fever-outbreaks-gabon-1994-1997 Lassa fever. Epidemiological aspects of the 1970 epidemic /resources/lassa-fever-epidemiological-aspects-1970-epidemic A restricted, hospital-centred outbreak of Lassa fever involving 28 persons occurred early in 1970 in Jos, Nigeria. 24 patients were in hospital. Every patient, save the index, could be traced to some prior known human source of infection. Complement-fixing antibody to Lassa virus was detected in the sera of only 4 of 172 family and hospital contacts bled. These 4 persons had all been ill. Animal studies have so far failed to reveal a non-human host. Fri, 03/29/2019 - 11:36 Dan /resources/lassa-fever-epidemiological-aspects-1970-epidemic Material Proximities and Hotspots: Toward an Anthropology of Viral Hemorrhagic Fevers /resources/material-proximities-and-hotspots-toward-anthropology-viral-hemorrhagic-fevers This article outlines a research program for an anthropology of viral hemorrhagic fevers (collectively known as VHFs). It begins by reviewing the social science literature on Ebola, Marburg, and Lassa fevers and charting areas for future ethnographic attention. We theoretically elaborate the hotspot as a way of integrating analysis of the two routes of VHF infection: from animal reservoirs to humans and between humans. Drawing together recent anthropological investigations of human–animal entanglements with an ethnographic interest in the social production of space, we seek to enrich conceptualizations of viral movement by elaborating the circumstances through which viruses, humans, objects, and animals come into contact. We suggest that attention to the material proximities—between animals, humans, and objects—that constitute the hotspot opens a frontier site for critical and methodological development in medical anthropology and for future collaborations in VHF management and control. Fri, 03/29/2019 - 11:34 Dan /resources/material-proximities-and-hotspots-toward-anthropology-viral-hemorrhagic-fevers Lassa fever is unheralded problem in West Africa /resources/lassa-fever-unheralded-problem-west-africa Lassa Fever is a zoonotic viral haemorrhagic fever endemic across sub-Saharan western Africa. This means it is an animal disease that can be spread to humans, with symptoms that include high fever and (sometimes) bleeding. The primary reservoir is the multimammate mouse, Mastomys natalensis, however new evidence is emerging that other rodents also carry the disease, such as the African wood mouse species Hylomyscus pamfi in Nigeria, and the Guinea multimammate mouse Mastomys erythroleucus. Most infections of Lassa fever occur from direct or indirect contact with infected rodents. Lassa fever can also be spread from human to human through contact with infected fluids, such as blood, although this can be prevented through the use of barrier nursing techniques. As human to human transmission can occur within communities as well as in health-care settings, the level to which appropriate barrier nursing can be used is dependent on local resources, living conditions, and sanitation. Fri, 03/15/2019 - 14:38 Dan /resources/lassa-fever-unheralded-problem-west-africa Sierra Leone continues to struggle for relief from Lassa fever /resources/sierra-leone-continues-struggle-relief-lassa-fever This short article in The Lancet describes the issues faced by the medical relief charity MERLIN, which provides Lassa fever services in Sierra Leone, during and after the civil war.  Fri, 03/29/2019 - 13:14 Dan /resources/sierra-leone-continues-struggle-relief-lassa-fever Nigeria Centre for Disease Control (NCDC): Viral haemorrhagic fever factsheet /resources/nigeria-centre-disease-control-ncdc-viral-haemorrhagic-fever-factsheet Overview information for viral haemorrhagic fevers relating to background, transmission, symptoms, diagnosing/testing, and treatment. Fri, 03/29/2019 - 13:19 Dan /resources/nigeria-centre-disease-control-ncdc-viral-haemorrhagic-fever-factsheet Mystery virus from Lassa /resources/mystery-virus-lassa Two sisters, both with a deep and abiding religious faith, tell the story of their involvement with a severe but unknown viral disease. One is a missionary nurse. Lily, who caught the disease; the other is Rose, who cared for her when she was brought back to the States. The shared story began with a letter from Lily. Fri, 03/29/2019 - 13:27 Dan /resources/mystery-virus-lassa Understanding the cryptic nature of Lassa fever in West Africa /resources/understanding-cryptic-nature-lassa-fever-west-africa-0 Lassa fever (LF) is increasingly recognized by global health institutions as an important rodent-borne disease with severe impacts on some of West Africa’s poorest communities. However, our knowledge of LF ecology, epidemiology and distribution is limited, which presents barriers to both short-term disease forecasting and prediction of long-term impacts of environmental change on Lassa virus (LASV) zoonotic transmission dynamics. Here, we synthesize current knowledge to show that extrapolations from past research have produced an incomplete picture of the incidence and distribution of LF, with negative consequences for policy planning, medical treatment and management interventions. Although the recent increase in LF case reports is likely due to improved surveillance, recent studies suggest that future socio-ecological changes in West Africa may drive increases in LF burden. Future research should focus on the geographical distribution and disease burden of LF, in order to improve its integration into public policy and disease control strategies. Fri, 03/29/2019 - 13:31 Dan /resources/understanding-cryptic-nature-lassa-fever-west-africa-0 Lassa fever in post-conflict Sierra Leone /resources/lassa-fever-post-conflict-sierra-leone Lassa fever (LF) is a major public health threat in West Africa. After the violent civil conflict in Sierra Leone (1991 to 2002) ended, the LF research program at Kenema Government Hospital (KGH) was reestablished. Higher case fatality rates in LF patients were observed compared to studies conducted prior to the civil conflict. The criteria used for defining the stages of LF and differences in sensitivity of the assays used likely account for these differences. LF may be more widespread in Sierra Leone than recognized previously. Peak presentation of LF cases occurs in the dry season, which is consistent with previous studies. This paper's studies also confirmed reports conducted prior to the civil conflict that indicate that infants, children, young adults, and pregnant women are disproportionately impacted by LF. High fatality rates were observed among both ribavirin treated and untreated patients, which underscores then need for better LF treatments. Fri, 03/29/2019 - 13:33 Dan /resources/lassa-fever-post-conflict-sierra-leone